Peter Mollee - Concepedia

Author

Peter Mollee

Also Known As

Dr Peter Mollee, Mollee, P, Mollee, PN, Mollee, Peter, P Mollee, P N Mollee, P. Mollee, P. N. MOLLEE, P. N. Mollee, P., Mollee

385

Publications

6.1K

Citations

H-Index

136

Concepts

All Affiliations

Princess Alexandra Hospital The University of Queensland Royal Brisbane and Women's Hospital Peter MacCallum Cancer Centre Monash University

About

Peter Mollee is an author at Princess Alexandra Hospital specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	34	1.6K
2	Health Sciences	11	11	280
3	Public Health	3	3	189
4	Engineering	2	2	94
5	Allergy	1	1	13

Peter Mollee

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis Efstathios Kastritis, Giovanni Palladini, Monique C. Minnema, New England Journal of Medicine	2021	609
Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial Ralf Ulrich Trappe, Stephan Oertel, Véronique Leblond, The Lancet Oncology Lymphoid NeoplasiaPtld-1 TrialTransplantationMedicineImmunology	2011	379
Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial Ralf Ulrich Trappe, Daan Dierickx, Heiner Zimmermann, Journal of Clinical Oncology	2017	219
Cardiac Amyloid Imaging with<sup>18</sup>F-Florbetaben PET: A Pilot Study W. Phillip Law, William Y.S. Wang, Peter Moore, Journal of Nuclear Medicine	2016	176
Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration Joshua W.D. Tobin, Colm Keane, Jay Gunawardana, Journal of Clinical Oncology	2019	157
Catheter-associated bloodstream infection incidence and risk factors in adults with cancer: a prospective cohort study Peter Mollee, Mark Jones, Jenny Stackelroth, Journal of Hospital Infection Cancer EpidemiologyMedicineHealthcare-associated InfectionPatient SafetyEpidemiology Of Cancer	2011	147
Bortezomib, Melphalan, and Dexamethasone for Light-Chain Amyloidosis Efstathios Kastritis, Xavier Leleu, Bertrand Arnulf, Journal of Clinical Oncology	2020	140
Plasma Epstein-Barr Virus (EBV) DNA Is a Biomarker for EBV-Positive Hodgkin's Lymphoma Maher K. Gandhi, Eleanore Lambley, Jacqueline M. Burrows, Clinical Cancer Research	2006	137
Managing haematology and oncology patients during the <scp>COVID</scp> ‐19 pandemic: interim consensus guidance Robert Weinkove, Zoe McQuilten, Jonathan M. Adler, The Medical Journal of Australia	2020	126
Autologous stem cell transplant for relapsed and refractory peripheral T‐cell lymphoma: variable outcome according to pathological subtype Kevin Song, Peter Mollee, Armand Keating, British Journal of Haematology	2003	103

Page 1